Compugen (CGEN) Reports In-Line Q3 EPS

Compugen (NASDAQ: CGEN) reported Q3 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $1.89 million versus the consensus estimate of $3.13 million.

For earnings history and earnings-related data on Compugen (CGEN) click here.

You May Also Be Interested In

• UBS Reiterates Buy Rating on nVent Electric (NVT)
• National Fuel Gas Company (NFG) Raises Quarterly Dividend 3.7% to $0.555; 2.9% Yield
• RBC Capital Reiterates Outperform Rating on BP Plc. (BP:LN) (BP)